IDEAYA Biosciences Management
How experienced are the management team and are they aligned to shareholders interests?
2.1yrs
Average management tenure
CEO
Yujiro Hata (48 yo)
7.75yrs
Tenure
US$3,848,871
Compensation
Mr. Yujiro S. Hata serves as an Independent Director at Enanta Pharmaceuticals, Inc. since August 29, 2021. He has been Co-Founder, Chief Executive Officer, President and Director of IDEAYA Biosciences, In...
CEO Compensation Analysis
| Date | Total Comp. | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2022 | n/a | n/a | -US$59m |
| Sep 30 2022 | n/a | n/a | -US$53m |
| Jun 30 2022 | n/a | n/a | -US$66m |
| Mar 31 2022 | n/a | n/a | -US$55m |
| Dec 31 2021 | US$4m | US$544k | -US$50m |
| Sep 30 2021 | n/a | n/a | -US$37m |
| Jun 30 2021 | n/a | n/a | -US$30m |
| Mar 31 2021 | n/a | n/a | -US$31m |
| Dec 31 2020 | US$2m | US$510k | -US$34m |
| Sep 30 2020 | n/a | n/a | -US$40m |
| Jun 30 2020 | n/a | n/a | -US$46m |
| Mar 31 2020 | n/a | n/a | -US$44m |
| Dec 31 2019 | US$2m | US$457k | -US$42m |
| Sep 30 2019 | n/a | n/a | -US$40m |
| Jun 30 2019 | n/a | n/a | -US$42m |
| Mar 31 2019 | n/a | n/a | -US$38m |
| Dec 31 2018 | US$2m | US$420k | -US$34m |
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 7.75yrs | US$3.85m | 1.38% $ 10.0m | |
| CFO & Principal Accounting Officer | 3.67yrs | US$1.80m | 0.029% $ 206.9k | |
| Chief Scientific Officer | 1.33yrs | US$3.58m | no data | |
| Co -Founder | no data | no data | no data | |
| VP and Head of Business Operations & IR | 2.17yrs | no data | no data | |
| Chief Technology Officer | 0.17yr | no data | no data | |
| Chief Legal Officer & Company Secretary | 3.42yrs | US$1.16m | no data | |
| VP and Head of Medical Affairs & Clinical Oncology | 2.08yrs | no data | no data | |
| Senior Vice President of Development Operations | 1yr | no data | no data | |
| Chief Medical Officer | 0.33yr | no data | no data |
2.1yrs
Average Tenure
53yo
Average Age
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 7.75yrs | US$3.85m | 1.38% $ 10.0m | |
| Independent Director | 3.25yrs | US$225.98k | 0.015% $ 110.0k | |
| Independent Director | 7.42yrs | US$229.43k | 0.0089% $ 64.2k | |
| Independent Chairman of the Board | 7yrs | US$258.98k | 0% $ 0 | |
| Independent Director | 2.08yrs | US$361.99k | 0% $ 0 | |
| Chair of Scientific Advisory Board | 4.08yrs | no data | no data | |
| Independent Director | 4.67yrs | US$232.48k | 0% $ 0 | |
| Member of Scientific Advisory Board | 6.83yrs | no data | no data | |
| Member of Scientific Advisory Board | 4.08yrs | no data | no data | |
| Member of Scientific Advisory Board | 6.83yrs | no data | no data | |
| Independent Director | 7.17yrs | US$218.48k | 0.034% $ 245.0k | |
| Independent Director | 2.75yrs | US$217.48k | 0% $ 0 |
5.8yrs
Average Tenure
63.5yo